当前位置: X-MOL 学术Eur. Heart J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up.
European Heart Journal ( IF 37.6 ) Pub Date : 2022-03-14 , DOI: 10.1093/eurheartj/ehab697
, Colin Baigent , Stephan Windecker , Daniele Andreini , Elena Arbelo , Emanuele Barbato , Antonio L Bartorelli , Andreas Baumbach , Elijah R Behr , Sergio Berti , Héctor Bueno , Davide Capodanno , Riccardo Cappato , Alaide Chieffo , Jean-Philippe Collet , Thomas Cuisset , Giovanni de Simone , Victoria Delgado , Paul Dendale , Dariusz Dudek , Thor Edvardsen , Arif Elvan , José R González-Juanatey , Mauro Gori , Diederick Grobbee , Tomasz J Guzik , Sigrun Halvorsen , Michael Haude , Hein Heidbuchel , Gerhard Hindricks , Borja Ibanez , Nicole Karam , Hugo Katus , Fredrikus A Klok , Stavros V Konstantinides , Ulf Landmesser , Christophe Leclercq , Sergio Leonardi , Maddalena Lettino , Giancarlo Marenzi , Josepa Mauri , Marco Metra , Nuccia Morici , Christian Mueller , Anna Sonia Petronio , Marija M Polovina , Tatjana Potpara , Fabien Praz , Bernard Prendergast , Eva Prescott , Susanna Price , Piotr Pruszczyk , Oriol Rodríguez-Leor , Marco Roffi , Rafael Romaguera , Stephan Rosenkranz , Andrea Sarkozy , Martijn Scherrenberg , Petar Seferovic , Michele Senni , Francesco R Spera , Giulio Stefanini , Holger Thiele , Daniela Tomasoni , Lucia Torracca , Rhian M Touyz , Arthur A Wilde , Bryan Williams

AIMS Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular (CV) disease in association with COVID-19. METHODS AND RESULTS A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, which was reported previously, focused on the epidemiology, pathophysiology, and diagnosis of CV conditions that may be manifest in patients with COVID-19. This second part addresses the topics of: care pathways and triage systems and management and treatment pathways, both of the most commonly encountered CV conditions and of COVID-19; and information that may be considered useful to help patients with CV disease (CVD) to avoid exposure to COVID-19. CONCLUSION This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.

中文翻译:


ESC 关于 COVID-19 大流行期间心血管疾病诊断和管理的指南:第 2 部分 - 护理途径、治疗和随访。



自2020年初出现以来,导致2019冠状病毒病(COVID-19)的新型严重急性呼吸综合征冠状病毒2(COVID-19)已达到大流行水平,并在全球范围内反复暴发。这两个系列的目的是提供实用知识和指导,帮助临床医生诊断和管理与 COVID-19 相关的心血管 (CV) 疾病。方法和结果对现有证据进行了叙述性文献综述,所得信息分为两部分。第一个研究先前已报道,重点关注 COVID-19 患者可能出现的心血管疾病的流行病学、病理生理学和诊断。第二部分讨论以下主题:护理途径和分诊系统以及管理和治疗途径,这两种途径都是最常见的心血管疾病和 COVID-19;以及可能被认为有助于帮助心血管疾病 (CVD) 患者避免接触 COVID-19 的信息。结论 本综合评价不是正式指南,而是一份文件,为管理 CVD 和 COVID-19 患者的执业临床医生提供当前知识和指导的总结。这些建议主要是医疗保健提供者的观察和个人经验的结果。因此,随着知识的增加、前瞻性研究的证据以及大流行的变化,此处提供的信息可能会发生变化。同样,文件中提供的指导不应干扰地方和国家医疗机构提供的建议。
更新日期:2021-11-16
down
wechat
bug